Skip to main content
. 2008 Apr 1;65(6):871–878. doi: 10.1111/j.1365-2125.2008.03124.x

Figure 2.

Figure 2

Mean differences in percentage pharmacokinetic coverage between 10 mg once-daily (q.d.) extended-release oxybutynin, and 5 mg twice-daily (b.i.d.) immediate-release oxybutynin. The solid line represents differences with perfect compliance; broken line represents typical compliance patterns (shaded area is the standard deviation around the mean)